Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a study non-randomised and uncontrolled cross-sectional experimental/interventional study.
Consecutive subjects will be enrolled healthy, volunteer subjects to undergo a Cardio-RM examination on the new 3T MRI equipment.
The Cardio-RM examination to which they will undergo: does NOT involve the administration of contrast medium involves the performance of certain preliminary 'localisation' sequences.
Following the execution of the investigation the investigators will use the post-processing workstations to analyse the parametric sequences and extract the T1 and T2 values of the myocardium.
To minimise bias, two different investigators different experimenters independently evaluate the sequences, in order to assess inter-observer agreement; furthermore, to assess the stability of the acquisition of these sequences, temperature and humidity will be measured of the MRI room for each survey performed.
Cardiac MRI represents the gold standard for the in vivo differentiation of various types of cardiomyopathies, thanks to its ability to characterize tissue. Through specific parametric mapping sequences, cardiac MRI allows not only the identification but also the quantification of both focal and diffuse alterations that cannot be assessed with other techniques. These sequences enable the direct measurement of relaxation times T1 (spin-lattice) and T2 (spin-spin), expressed in milliseconds, thus providing the ability to differentiate various tissue alterations (e.g., inflammation, ischemia, edema, and fibrosis).
The usefulness of T1 mapping sequences in analyzing certain cardiomyopathies, such as cardiac involvement in Anderson-Fabry disease, amyloidosis, and hemochromatosis, is well-documented in the literature. Similarly, T2 mapping sequences are valuable for evaluating inflammatory processes and myocarditis. Parametric sequences are also used to assess rejection phenomena in patients undergoing cardiac transplantation and play a crucial role in evaluating various cardiomyopathies in their end-stage phases.
Despite the broad and promising applications of these sequences as reported in the literature, certain challenges persist in their use. Specifically, the normal values for these sequences vary depending on the type of sequence and the specific MRI equipment employed. In our department, these sequences have been routinely used in clinical practice with a 1.5T MRI machine, for which the normal values have already been established and documented. With the recent installation of a new 3T MRI system, it is therefore necessary to determine the normal values of parametric sequences in healthy subjects to enable their use in routine clinical practice and for research purposes involving patients with various types of cardiomyopathies.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Normal T1 mapping values at 3T | To establish the normal values of the T1 mapping with a 3T MRI in healthy subjects, measuring the mean and standard deviation of the values obtained from the specific sequence | Form date of examination until 3 months |
| Normal T2 mapping values at 3T | To establish the normal values of the T2 mapping with a 3T MRI in healthy subjects, measuring the mean and standard deviation of the values obtained from the specific sequence | Form date of examination until 3 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Healthy volunteers with a negative history of established cardiac disease
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Edoardo Rasciti, MD | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | Bologna | 40100 | Italy |
Not provided
Not provided
Not provided
Not provided